WordNet
- a long-playing phonograph record; designed to be played at 33.3 rpm (同)L-P
PrepTutorEJDIC
- エルピーレコード(1分間331/3回転のレコード;商標名)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 結節性リンパ球優位型ホジキンリンパ腫の治療 treatment of nodular lymphocyte predominant hodgkin lymphoma
- 2. びまん性大細胞型B細胞性リンパ腫の疫学、臨床症状、病理学的特徴、および診断 epidemiology clinical manifestations pathologic features and diagnosis of diffuse large b cell lymphoma
English Journal
- Milwaukee Laboratory System Improvement Program (L-SIP).
- Gradus MS1, Bhattacharyya S, Murphy A, Becker JN, Baker BK.Author information 1City of Milwaukee Health Department, Milwaukee, WI.AbstractThe Laboratory System Improvement Program (L-SIP) of the Association of Public Health Laboratories aims to improve state public health laboratory (PHL) system performance through continuous quality improvement. We successfully applied this state assessment tool to a local PHL (LPHL) system by tailoring it to reflect local system needs and created an LPHL system definition explaining how a local system differs from, yet complements, a state system. On November 18, 2010, 75 stakeholders from 40 agencies assessed the Milwaukee, Wisconsin, PHL system, capturing themes, strengths and weaknesses of the system, and scores for each of the 10 Essential Public Health Services. A Laboratory Advisory Committee analyzed assessment results to identify a strategic focus of research and workforce development and define an action plan, which is now being carried out. Milwaukee's L-SIP process is effectively improving LPHL system research and workforce development while raising community awareness of the system.
- Public health reports (Washington, D.C. : 1974).Public Health Rep.2013 Sep-Oct;128 Suppl 2:40-8.
- The Laboratory System Improvement Program (L-SIP) of the Association of Public Health Laboratories aims to improve state public health laboratory (PHL) system performance through continuous quality improvement. We successfully applied this state assessment tool to a local PHL (LPHL) system by tailor
- PMID 23997302
- Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.
- Appel BE1, Chen L, Buxton A, Wolden SL, Hodgson DC, Nachman JB.Author information 1Tomorrows Children's Institute, Hackensack University Medical Center, Hackensack, NJ 07601, USA. bappel@hackensackumc.orgAbstractBACKGROUND: Treatment of pediatric lymphocyte-predominant Hodgkin lymphoma (LPHL) is controversial but has typically consisted of both chemotherapy and radiation. Radiation therapy is associated with potential late effects in children and adolescents. We examined the impact of radiation therapy on long-term outcome of patients with LPHL treated on CCG-5942, a large pediatric cooperative group study of Hodgkin lymphoma (HL).
- Pediatric blood & cancer.Pediatr Blood Cancer.2012 Dec 15;59(7):1284-9. doi: 10.1002/pbc.24258. Epub 2012 Jul 27.
- BACKGROUND: Treatment of pediatric lymphocyte-predominant Hodgkin lymphoma (LPHL) is controversial but has typically consisted of both chemotherapy and radiation. Radiation therapy is associated with potential late effects in children and adolescents. We examined the impact of radiation therapy on l
- PMID 22847767
- Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.
- Hoppe RT1, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H; National Comprehensive Cancer Network.Author information 1Stanford Cancer Institute.AbstractThe NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin Lymphoma (HL) include the clinical management of classical HL and lymphocyte-predominant HL (LPHL). Major changes have been incorporated into these guidelines since their inception. In the 2012 NCCN Guidelines for HL, PET scans are not recommended for interim restaging of patients with stage I to II favorable disease. After reevaluating the available evidence on the use of interim PET imaging, the panel recommends the use of diagnostic CT scan of involved sites for interim restaging after completion of chemotherapy for this group of patients. Maintenance rituximab for 2 years is included as an option for patients with stage IB to IIB or stage III to IV LPHL treated with rituximab alone in the first-line setting. Brentuximab vedotin is included as an option for patients with progressive disease or relapsed disease after second-line chemotherapy or high-dose therapy with autologous stem cell rescue.
- Journal of the National Comprehensive Cancer Network : JNCCN.J Natl Compr Canc Netw.2012 May;10(5):589-97.
- The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin Lymphoma (HL) include the clinical management of classical HL and lymphocyte-predominant HL (LPHL). Major changes have been incorporated into these guidelines since their inception. In the 2012 NCCN Guidelines for HL, PE
- PMID 22570290
Japanese Journal
- ホジキンリンパ腫の治療指針 (特集 ホジキンリンパ腫 : 最近の話題)
- 血液・腫瘍科 57(6), 614-617, 2008-12
- NAID 40019063514
- タンパク質および脂質添加量の異なる飼料を給じしたサクラマス１才魚の成長およびスモルト出現数
- 日本水産学会誌 52(2), 313-318, 1986
- NAID 130001543070
Related Links
- Acronym Definition LPHL Lymphocyte Predominant Hodgkin Lymphoma ... Thinking community-wide about care management and population health is one of the defining elements of what the LPHL CCBC, and their collaborating ...
- What does LPHL stand for? LPHL stands for Lymphocyte Predominant Hodgkin Lymphoma. This definition appears very rarely The World's most comprehensive professionally edited abbreviations and acronyms database ... Local ...
Related Pictures
★リンクテーブル★
| 拡張検索 | 「NLPHL」 |
| 関連記事 | 「LP」「LPH」 |
「NLPHL」
「LP」